Check-Cap Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Check-Cap Ltd
Access all reports
Check-Cap Ltd. is a medical diagnostics company focused on the development of capsule-based screening technology aimed at detecting colorectal cancer in its early stages. The company's primary product is the C-Scan system, which utilizes a non-invasive, patient-friendly capsule that scans the inner lining of the colon using ultra-low-dose X-rays. This system generates detailed 3D maps of the colon's contours, allowing physicians to identify precancerous polyps and other abnormalities without the need for traditional bowel preparation or invasive procedures. The technology aims to improve patient compliance with colorectal cancer screening protocols globally. The company is headquartered in Isfiya, Israel, and its shares are listed on the NASDAQ.
Latest articles
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
CHEK
Country
πΊπΈ United States